Metformin glycinate/Sulfonylurea

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMetformin glycinate/Sulfonylurea
Drug Alias NameMetformin glycinate+Sulfonylurea甘氨二甲双胍/磺酰脲类磺酰脲类/甘氨二甲双胍Sulfonylurea/Metformin glycinateSulfonylurea+Metformin glycinate
ClassificationSmall molecules
Mechanisms of ActionAMP-activated protein kinases activatorsInsulin sensitizersProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1AMP-activated protein kinases
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Metformin glycinate
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Silanes
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratorios Silanes
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A